Skip to content

Apotheek P. Hostens: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek P. Hostens

BE 0406.780.386
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€91,185
2024 · €94,543-€3,358
Equity
€634,253
2024 · €568,068+€66,185
Cash
€386,362
2024 · €335,022+€51,339
Balance sheet total
€738,383
2024 · €626,312+€112,071

Largest movements

2024 to 2025
Assets
  • Current investments +€68,518

    up €68,518 (+198%), from €34,686 to €103,203

  • Cash +€51,339

    up €51,339 (+15.3%), from €335,022 to €386,362

    mainly Net result for the year (+€91,185) and Depreciation (+€19,094)

  • Receivables within one year +€15,750

    up €15,750 (+19.2%), from €81,867 to €97,618

    of which Trade receivables: +€22,970

  • Tangible fixed assets -€15,312

    down €15,312 (-31.9%), from €48,041 to €32,729

    of which Furniture and vehicles: -€17,833

Equity and liabilities
  • Reserves +€66,185

    up €66,185 (+11.9%), from €555,710 to €621,895

    of which Distributable reserves: +€66,185

  • Other debts +€18,050

    up €18,050 (+163%), from €11,078 to €29,128

  • Trade debts +€17,572

    up €17,572 (+47.5%), from €36,990 to €54,561

  • Tax, wage and social debts +€12,501

    up €12,501 (+162%), from €7,719 to €20,220

    of which Taxes: +€8,479

Income statement
  • Staff costs +€23,532

    up €23,532 (+52.5%), from €44,835 to €68,367

  • Gross operating margin +€18,803

    up €18,803 (+10.1%), from €186,549 to €205,352

  • Financial income +€11,737

    up €11,737 (+708%), from €1,658 to €13,395

    of which Non-recurring financial income: +€11,381

  • Taxes +€11,632

    up €11,632 (+44.4%), from €26,178 to €37,810

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €94,543
Gross operating margin +€18,803
Staff costs -€23,532
Depreciation -€610
Other operating charges +€123
Financial income +€11,737
Financial charges +€1,752
Taxes -€11,632
Result 2025 €91,185
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€148,639
Investment -€72,299
Financing -€25,000
Cash 2024 €335,022
Net result for the year +€91,185
Depreciation +€19,094
Stocks and contracts +€5,074
Receivables within one year -€15,750
Deferred charges and accrued income +€3,151
Trade debts +€17,572
Tax, wage and social debts +€12,501
Other debts +€18,050
Accrued charges and deferred income -€2,236
Investment in fixed assets (net) -€3,782
Current investments -€68,518
Contributions, distributions and other -€25,000
Cash 2025 €386,362
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €626,312 €738,383 +€112,071 +17.9%
Fixed assets 21/28 €48,412 €33,100 -€15,312 -31.6%
Tangible fixed assets 22/27 €48,041 €32,729 -€15,312 -31.9%
Plant, machinery and equipment 23 €2,245 €5,328 +€3,084 +137%
Furniture and vehicles 24 €44,670 €26,837 -€17,833 -39.9%
Other tangible fixed assets 26 €1,126 €563 -€563 -50.0%
Financial fixed assets 28 €372 €372 = 0.0%
Current assets 29/58 €577,899 €705,283 +€127,383 +22.0%
Stocks and contracts in progress 3 €110,559 €105,485 -€5,074 -4.6%
Stocks 30/36 €110,559 €105,485 -€5,074 -4.6%
Amounts receivable within one year 40/41 €81,867 €97,618 +€15,750 +19.2%
Trade receivables 40 €74,013 €96,984 +€22,970 +31.0%
Other amounts receivable 41 €7,854 €634 -€7,220 -91.9%
Current investments 50/53 €34,686 €103,203 +€68,518 +198%
Cash at bank and in hand 54/58 €335,022 €386,362 +€51,339 +15.3%
Deferred charges and accrued income 490/1 €15,766 €12,615 -€3,151 -20.0%
Total equity and liabilities 10/49 €626,312 €738,383 +€112,071 +17.9%
Equity 10/15 €568,068 €634,253 +€66,185 +11.7%
Contributions 10/11 €12,358 €12,358 = 0.0%
Reserves 13 €555,710 €621,895 +€66,185 +11.9%
Tax-exempt reserves 132 €2,500 €2,500 = 0.0%
Distributable reserves 133 €553,210 €619,395 +€66,185 +12.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €58,243 €104,130 +€45,886 +78.8%
Amounts payable within one year 42/48 €55,787 €103,909 +€48,122 +86.3%
Trade debts 44 €36,990 €54,561 +€17,572 +47.5%
Suppliers 440/4 €36,990 €54,561 +€17,572 +47.5%
Taxes, remuneration and social security 45 €7,719 €20,220 +€12,501 +162%
Taxes 450/3 €4,585 €13,065 +€8,479 +185%
Remuneration and social security 454/9 €3,133 €7,155 +€4,021 +128%
Other amounts payable 47/48 €11,078 €29,128 +€18,050 +163%
Accrued charges and deferred income 492/3 €2,457 €221 -€2,236 -91.0%
Remuneration, social security and pensions 62 €44,835 €68,367 +€23,532 +52.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,484 €19,094 +€610 +3.3%
Other operating charges 640/8 €1,510 €1,388 -€123 -8.1%
Gross operating margin 9900 €186,549 €205,352 +€18,803 +10.1%
Operating profit (loss) 9901 €121,719 €116,503 -€5,216 -4.3%
Financial income 75/76B €1,658 €13,395 +€11,737 +708%
Recurring financial income 75 €1,658 €2,014 +€355 +21.4%
Non-recurring financial income 76B - €11,381 +€11,381
Financial charges 65/66B €2,656 €904 -€1,752 -66.0%
Recurring financial charges 65 €2,656 €904 -€1,752 -66.0%
Profit (loss) for the period before taxes 9903 €120,721 €128,994 +€8,273 +6.9%
Income taxes 67/77 €26,178 €37,810 +€11,632 +44.4%
Profit (loss) for the period 9904 €94,543 €91,185 -€3,358 -3.6%
Profit (loss) for the period to be appropriated 9905 €94,543 €91,185 -€3,358 -3.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.